Glycemia reduction approaches in diabetes: a comparative effectiveness study

Ended Cooperative Agreement Awarded Last action

Award ID
U01DK098246
Recipient
Awarding agency
Obligated
$255,927,545

Award facts

Completion date
Originally
Funding
  • $248,994,246.00 Federal
  • $6,933,299.00 Non-federal
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $3,162,825 $0
Amendment $3,162,825 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $6,933,299 $0
Amendment $250,000 $0
Amendment $6,933,299 $6,933,299
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment -$1,548 $0
Amendment $1,548 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $250,000 $0
Amendment $100,000 $0
Amendment Continuation of the glycemia reduction approaches in diabetes: a comparative effectiveness (grade) study $26,574,216 $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
The General Hospital Corporation Continuation of GLYCEMIA REDUCTION APPROACHES IN DIABETES: A COMPARATIVE EFFECTIVENESS STUDY $16,509
Albert Einstein College Of Medicine $6,389
Duke University $2,865
The Trustees Of Columbia University In The City Of New York Continuation of GLYCEMIA REDUCTION APPROACHES IN DIABETES: A COMPARATIVE EFFECTIVENESS STUDY (GRADE) $27,693
The General Hospital Corporation Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) $38,957
The University Of Iowa Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (QA Review on FFATA Reporting) $40,066
University Of New Mexico Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) $8,761
University Of Alabama At Birmingham Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (QA Review on FFATA Reporting) $71,502
Healthpartners Institute Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) $11,584
Albert Einstein College Of Medicine $74,464
University Of North Carolina At Chapel Hill $26,000
Regents Of The University Of Michigan Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (QA Review on FFATA Reporting) $193,312
Veterans Medical Research Foundation Of San Diego Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) $44,959
Regents Of The University Of Minnesota $14,003
The General Hospital Corporation $78,598
The Research Foundation For The State University Of New York $68,687
Vanderbilt University Medical Center Continuation of the glycemia reduction approaches in diabetes: a comparative effectiveness (grade) study $12,602
Wake Forest University Health Sciences Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $11,969
Duke University Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) $55,298
Oregon Health & Science University $23,200
Seattle Institute For Biomedical And Clinical Research -$41,924
The General Hospital Corporation $36,621
The Washington University Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $3,114
The Research Foundation For The State University Of New York $50,849
The General Hospital Corporation Continuation of GLYCEMIA REDUCTION APPROACHES IN DIABETES: A COMPARATIVE EFFECTIVENESS STUDY (GRADE) $112,585
Regents Of The University Of Minnesota $104,252
The General Hospital Corporation Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $88,879
Cincinnati Univ Of Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). $27,083
Duke University Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $58,068
Oregon Health & Science University Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). $53,133
University Of New Mexico Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $48,875
Regents Of The University Of Michigan $353,312
The Regents Of The University Of Colorado $56,295
South Florida Veterans Affairs Foundation For Research And Education, Inc. $61,983
Regents Of The University Of Michigan $44,880
The University Of Texas Health Science Center At San Antonio $32,831
The Trustees Of Columbia University In The City Of New York Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). $48,757
Baylor College Of Medicine Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study (QA Review on FFATA Reporting) $37,658
The University Of Iowa Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $35,221
Board Of Regents Of The University Of Nebraska Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). $40,069
Healthpartners Institute Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study. $25,000
University Of North Carolina At Chapel Hill Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $79,517
Wake Forest University Health Sciences $10,193
University Of Alabama At Birmingham $79,281
Icahn School Of Medicine At Mount Sinai Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). $32,688
Pennington Biomedical Research Center Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $41,730
Kaiser Foundation Hospitals $23,113
University Of California, San Diego Continuation of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). $15,887
Seattle Institute For Biomedical And Clinical Research $65,483
Albert Einstein College Of Medicine Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study $12,000
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who received award U01DK098246?

U01DK098246 was awarded to George Washington University (The) by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 25, 2012.

How much is award U01DK098246 worth?

$255,927,545 has been obligated on U01DK098246: $248,994,246 in federal funding and $6,933,299 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login